articleTop 10% cited
Short and long‐term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome
Clinical Endocrinology · 1991 · Vol. 35(2) · pp. 169–178
J. Verhelst✉(St Bartholomew's Hospital)Peter Trainer(St Bartholomew's Hospital)Trevor A. Howlett(St Bartholomew's Hospital)Les Perry(St Bartholomew's Hospital)Lesley Rees(St Bartholomew's Hospital)Ashley Grossman(St Bartholomew's Hospital)John Wass(St Bartholomew's Hospital)G. M. Sesser(St Bartholomew's Hospital)
Abstract
In our experience metyrapone remains a most useful agent for controlling cortisol levels in the management of Cushing's syndrome of all types.
Pituitary Gland Disorders and TreatmentsAdrenal Hormones and DisordersAdrenal and Paraganglionic TumorsMetyraponeMedicineInternal medicineEndocrinologyCushing's diseaseAdrenocorticotropic hormoneHydrocortisoneGastroenterologyDiseaseHormone
MeSH terms
ACTH Syndrome, EctopicAdenomaAdolescentAdrenal Cortex NeoplasmsAdrenocorticotropic HormoneAdultAgedCarcinomaCortodoxoneCushing SyndromeDepression, ChemicalFemaleHumansHydrocortisoneMale
Citations
310
FWCI
3.51
field-weighted impact
References
27
Percentile
93%
vs. same field & year
Citations per year
Cited by
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism · 2015 · 1,215 citations
References
DIAGNOSIS AND MANAGEMENT OF ACTH‐DEPENDENT CUSHING'S SYNDROME: COMPARISON OF THE FEATURES IN ECTOPIC AND PITUITARY ACTH PRODUCTION
Clinical Endocrinology · 1986 · 308 citations
A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma
Journal of Clinical Pathology · 1962 · 1,185 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.